Immunotherapy |
Camrelizumab combined with apatinib for recurrent resistant GTN |
NCT04047017 |
Completed |
|
Pebrolizumab for resistant GTN |
NCT04303884 |
Not yet recruiting |
|
Camrelizumab combined with apatinib in patients with high-risk GTN |
NCT05139095 |
Not yet recruiting |
|
Avelumab combined with methotrexate for low-risk GTN |
NCT04396223 |
Recruiting |
|
Avelumab in chemo-resistant GTN |
NCT03135769 |
Completed |
|
Camrelizumab combined with bevacizumab in high-risk GTN after combined chemotherapy |
NCT04812002 |
Recruiting |
|
TRC105 and/or bevacizumab in refractory GTN |
NCT02664961 |
Terminated |
Chemotherapy |
Paclitaxel plus cisplatin vs EMA-CO in high-risk GTN |
NCT02639650 |
Unknown |
|
Rescue regimen with MTX vs high-dose MTX protocol in persistent GTN |
NCT03280979 |
Unknown |
|
Pemetrexed disodium as salvage therapy for failed low-risk GTN |
NCT00096187 |
Terminated |
|
Dactinomycin in patients with persistent or recurrent low-risk GTN |
NCT00003688 |
Completed |
|
Single dose MTX vs MTX and Actinomycin-D single dose vs MTX multiple courses |
NCT01823315 |
Unknow |
|
Biweekly actinomycin-D treatment vs multi-day methotrexate in low-risk GTN |
NCT04562558 |
Recruiting |
|
Methotrexate vs dactinomycin in low-risk GTN |
NCT00003702 |
Completed |
|
Methotrexate for prevention of postmolar GTN |
NCT01984099 |
Completed |
|
Dactinomycin vs methotrexate in low-risk GTN |
NCT01535053 |
Completed |
|
Chemotherapy vs follow up in hydatidiform mole with lung nodule |
NCT03785574 |
Recruiting |
|
Pemetrexed in recurrent or persistent low-risk GTN |
NCT00190918 |
Completed |
|
Methotrexate vs methotrexate plus actinomycin in low-risk GTN patients with score 5-6 |
NCT03885388 |
Recruiting |
Surgical treatment |
Hysteroscopic repeat curettage vs methotrexate in low-risk GTN |
NCT03703271 |
Recruiting |
|
Total abdominal hysterectomy and methotrexate vs methotrexate plus folinic acid |
NCT02606539 |
Unknown |
|
Second uterine evacuation vs chemotherapy in low-risk GTN |
NCT04756713 |
Recruiting |
|
Second curettage in low-risk, non-metastatic GTN |
NCT00521118 |
Completed |
|
Single evacuation vs double evacuation of mole |
NCT01630954 |
Unknown |